MARKET

AWH

AWH

Aspira Womens Health Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5899
+0.0098
+1.69%
Opening 10:41 05/19 EDT
OPEN
0.5950
PREV CLOSE
0.5801
HIGH
0.6130
LOW
0.5566
VOLUME
255.26K
TURNOVER
--
52 WEEK HIGH
6.25
52 WEEK LOW
0.3210
MARKET CAP
66.19M
P/E (TTM)
-1.8883
1D
5D
1M
3M
1Y
5Y
Does Aspira Women's Health (NASDAQ:AWH) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Simply Wall St. · 1d ago
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th \- 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global ...
ACCESSWIRE · 3d ago
Aspira Women’s Health to Participate in the Upcoming Investor Conferences
AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that management will participate in the “MicroCap Rodeo Spring Into Action Best Ideas” Conference virtua...
GlobeNewswire · 05/12 20:01
BRIEF-Aspira Women’S Health Reports First Quarter 2022 Financial Results
reuters.com · 05/11 11:34
Aspira Women’s Health Reports First Quarter 2022 Financial Results
Product Revenue Increased 30% to $1.8 million; OVA1plus Volume Grew 28% to 4,819 Units New Ordering Physicians in the First Quarter Grew 47% to 603 Year Over Year Board and Leadership appointments announced Conference Call and Webcast scheduled for today, ...
GlobeNewswire · 05/11 11:30
Aspira Women’s Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11
AUSTIN, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the first quarter ended March 31, 2022 before ...
GlobeNewswire · 04/29 12:00
What Kind Of Shareholders Hold The Majority In Aspira Women's Health Inc.'s (NASDAQ:AWH) Shares?
If you want to know who really controls Aspira Women's Health Inc. ( NASDAQ:AWH ), then you'll have to look at the...
Simply Wall St. · 04/02 17:40
BRIEF-Aspira Women's Health Says Q4 Net Loss Diluted Per Share $0.08
reuters.com · 03/23 11:59
More
No Data
Learn about the latest financial forecast of AWH. Analyze the recent business situations of Aspira Womens Health Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AWH stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.
High3.000
Average3.000
Low3.000
Current 0.5501
EPS
Actual
Estimate
-0.07-0.05-0.04-0.02
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 115
Institutional Holdings: 34.27M
% Owned: 30.54%
Shares Outstanding: 112.21M
TypeInstitutionsShares
Increased
31
4.00M
New
21
613.72K
Decreased
31
3.82M
Sold Out
15
2.04M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.00%
Pharmaceuticals & Medical Research
+0.51%
Key Executives
Chairman/Executive Director
Valerie Palmieri
President/Chief Executive Officer/Director
Nicole Sandford
Chief Financial Officer
Robert Beechey
Chief Operating Officer/Chief Scientific Officer
Ryan Phan
General Counsel/Secretary
Mint Merchant
Lead Director/Independent Director
James Lafrance
Independent Director
Celeste Fralick
Independent Director
Veronica Jordan
No Data
No Data
About AWH
Aspira Women's Health Inc. is engaged in discovering, developing and commercialization of diagnostic and bio-analytical solutions that help physicians to diagnose, treat and improve gynecologic health outcomes for women. Its products include OVA1, Overa and OVA1plus. OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at high-risk of having a malignant ovarian tumor prior to planned surgery. OVERA is a second-generation biomarker panel intended to maintain OVA1's high sensitivity while improving specificity. OVA1plus is a reflex offering, which uses OVA1 primarily and OVERA as a confirmation for OVA1 intermediate range results. It is also developing three additional products and related services, including two diagnostic algorithms, OVASight and EndoCheck, and a high-risk diagnostic algorithm, OVAInherit, for patients with or without a pelvic mass who are genetically predisposed to ovarian cancer.

Webull offers kinds of Aspira Women's Health Inc stock information, including NASDAQ:AWH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AWH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AWH stock methods without spending real money on the virtual paper trading platform.